Quest Diagnostics News

Prescription history profiling tool translates Rx claims information 06-24-2015

June 24, 2015 - As an underwriter, wouldn’t it be great if you could gather greater insights into your applicants’ prescription history? What if there was a tool that helped facilitate precision underwriting?

In fall of 2014, ExamOne acquired MedPoint from OptumInsight. As part of ExamOne and Quest Diagnostics, our prescription database increased, providing you with a more in-depth review of your applicants’ prescription history. ScriptCheck® is now a more powerful tool aiding in the underwriting process.

Better data. More savings.

How does using ScriptCheck save you money? Underwriters tell us they only use three years of eligibility data to make decisions — anything more than that isn’t used. So while we receive the same seven years of eligibility as competitors do, we only provide the last three years to underwriters. This data is clean, accurate prescription data that allows you to make informed underwriting decisions about your applicants.

Additionally, as part of the new ownership ExamOne gained access to new data sources. Our database now provides access to over three billion new claims and eligibility records for clients. This provides our clients on average a 16 percent increase in hit rates.

Exclusive access to OptumRX

Quest Diagnostics has exclusive access to OptumRX claims information. OptumRX, owned by UnitedHealth Group is the third largest pharmacy benefit manager (PBM) in the country and is the preferred PBM of UnitedHealthcare. This data provides a more comprehensive review of your applicant’s prescription drug history.

Cleaner data, straight from the source

We currently access more than 70 percent of the PBM market. How does this affect you and your underwriting decisions? Through our PBM relationships we go directly to the source and collect the pharmacy claims regardless of where they fill their prescriptions. By using this strategy, you receive information on the drugs you care about for underwriting. It recognizes mail order maintenance as well as specialty drugs, in addition to any retail prescription purchases. This data approach provides you with the most complete and accurate picture of your applicant’s Rx claims history.

More intelligent design

With ScriptCheck’s new design, it will recognize when two names in the system are in fact the same individual. For example, a female fills a prescription, gets married a month later and changes her last name. The next time she fills a prescription her last name has changed. Our sophisticated algorithm will recognize this as the same individual and will combine all prescription history for both names. This same algorithm will also identify when two individuals who are on the same insurance plan, are not the same person.

Additionally, with this new infrastructure you will experience improved functionality. The new design will help you:

  • Identify potential diseases based on an individual’s prescription history
  • Determine if an applicant is following their maintenance drug plans as prescribed
  • Identify drug interactions that could be causing medical problems
  • Recognize specialties of all the doctors prescribing medication to your applicants
  • Uncover hidden health issues

We are excited about this new investment and the benefits it will provide to you. As a leader in the insurance industry, we are committed to helping our clients obtain the best and most accurate data, while also facilitating precision underwriting.

To find out more please contact our Product Manager, Stacy Steuart, at Stacy.R.Steuart@ExamOne.com.

 

Read More

June is Men's Health Month 06-19-2015

June 15, 2015 - This June, ExamOne is committed to raising awareness about men’s health. Many serious health conditions can be prevented or detected early with regular checkups.

Below are some of the regular screenings recommended for men1:

  • High blood cholesterol – Regular testing is recommended for men over 35. High blood cholesterol increases chances for heart disease, stroke and poor circulation.
  • Blood pressure – A blood pressure checkup every two years can reduce the risk of strokes, heart attacks, kidney and eye problems and heart failure.
  • Colon cancer – Beginning at age 50, men should be tested regularly for colorectal cancer, and the frequency of testing depends on the type of screen conducted. If there is family history of colorectal cancer, testing may need to begin before age 50.
  • Diabetes – Men with a blood pressure higher than 135/80 should talk with their doctor about a diabetes screening.

According to the Centers for Disease Control and Prevention, women are 100 percent more likely than men to seek preventive healthcare. Regular screenings can help catch these serious diseases early when they are easier to treat.

One metric used to evaluate an applicant’s risk of heart disease is the cholesterol/HDL ratio. With the increased focus on personal health and advancement of medical technology and pharmaceuticals (statins2), we have seen the cholesterol/HDL ratio improve significantly over the years. In 2009, 51 percent of our tested male insurance population had normal cholesterol/HDL ratios. Over the past five years, that rate has increased to 60 percent.

Quest Diagnostics offers an easy-to-use test to screen for colorectal cancer, known as InSure® FIT™. This in-home, water-based test kit makes it easy for individuals to complete the screening. InSure FIT is proven to detect stages I-III of colorectal cancers and requires no food or medicinal restrictions and no fecal handling. Learn more about the InSure FIT test.

Show your support for men’s health by wearing blue this month, and get more information about prevention from MensHealthMonth.org.

-----------------------------------------

1Men: Stay Healthy at Any Age: 2014 Update. March 2014. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/patients-consumers/patient-involvement/healthy-men/healthy-men.html

2Statins are drugs that can lower cholesterol. They work by blocking a substance the body needs to make cholesterol. Statins may also help the body reabsorb cholesterol that has built up in plaques on artery walls, preventing further blockage in blood vessels and related heart attacks.

Read More

Recent Quest Diagnostics Health Trends™ Study Indicates Rise in Diabetes Diagnoses 05-12-2015

May 11, 2015 - A recent Quest Diagnostics study indicated a significant rise in new diabetes cases in states that expanded Medicaid eligibility under the Affordable Care Act. The study reported that in states that expanded Medicaid, newly identified cases of diabetes rose 23 percent, compared to just .4 percent in the states that did not expand the program. Quest’s study was based on results of hemoglobin A1C tests, which reflect long-term glucose in the blood.

ExamOne, a Quest Diagnostics company, provides valuable testing services to health plans and their members, including Medicaid. MediCheck™ is a dedicated data collection system offered by ExamOne that enables health plans to control the health risk assessment process.
The recent Quest study highlights the importance of regular health assessments for health plan members.
“Our study demonstrates the value of objective insights gleaned from aggregate diagnostic data for informing population health strategies that can promote better health outcomes,” said Jay Wohlgemuth, M.D., senior vice president and chief scientific officer – research, development and medical, Quest Diagnostics.
A key finding in the study said that people with diabetes were identified at earlier stages in states that expanded Medicaid. According to the study, Quest scientists found lower hemoglobin A1C levels in newly identified patients in expansion states versus those in non-expansion states.
Early diagnosis and treatment are key to managing chronic health conditions such as diabetes, and can reduce the risk of developing additional health complications. The goal of MediCheck is to assist health plans with the data collection necessary to identify risks, and ultimately provide a plan for members to manage their health. Whether the health risk assessment process uncovers new information or reinforces the existing recommendations of the member’s physician, the documentation of those conditions, along with the face-to-face coaching, can help ensure that health plans are not only HEDIS-ready, but also actively supporting member health.
“Our study demonstrates the value of objective insights gleaned from aggregate diagnostic data for informing population health strategies that can promote better health outcomes,” said Jay Wohlgemuth, M.D., senior vice president and chief scientific officer – research, development and medical, Quest Diagnostics.

A recent Quest Diagnostics study indicated a significant rise in new diabetes cases in states that expanded Medicaid eligibility under the Affordable Care Act. The study reported that in states that expanded Medicaid, newly identified cases of diabetes rose 23 percent, compared to just .4 percent in the states that did not expand the program. Quest’s study was based on results of hemoglobin A1C tests, which reflect long-term glucose in the blood.

ExamOne, a Quest Diagnostics company, provides valuable testing services to health plans and their members, including Medicaid. MediCheck™ is a dedicated data collection system offered by ExamOne that enables health plans to control the health risk assessment process.

The recent Quest study highlights the importance of regular health assessments for health plan members.

A key finding in the study said that people with diabetes were identified at earlier stages in states that expanded Medicaid. According to the study, Quest scientists found lower hemoglobin A1C levels in newly identified patients in expansion states versus those in non-expansion states.

Early diagnosis and treatment are key to managing chronic health conditions such as diabetes, and can reduce the risk of developing additional health complications. The goal of MediCheck is to assist health plans with the data collection necessary to identify risks, and ultimately provide a plan for members to manage their health. Whether the health risk assessment process uncovers new information or reinforces the existing recommendations of the member’s physician, the documentation of those conditions, along with the face-to-face coaching, can help ensure that health plans are not only HEDIS-ready, but also actively supporting member health.

Read More

June is Men's Health Month 06-17-2015

This June, ExamOne and the MediCheck team are committed to raising awareness about men’s health. Many serious health conditions can be prevented or detected early with regular checkups.

Below are some of the regular screenings recommended for men1:

  • High blood cholesterol – Regular testing is recommended for men over 35. High blood cholesterol increases chances for heart disease, stroke and poor circulation.
  • Blood pressure – A blood pressure checkup every two years can reduce the risk of strokes, heart attacks, kidney and eye problems and heart failure.
  • Colon cancer – Beginning at age 50, men should be tested regularly for colorectal cancer, and the frequency of testing depends on the type of screen conducted. If there is family history of colorectal cancer, testing may need to begin before age 50.
  • Diabetes – Men with a blood pressure higher than 135/80 should talk with their doctor about a diabetes screening.

According to the Centers for Disease Control and Prevention, women are 100 percent more likely than men to seek preventative healthcare. Regular screenings can help catch these serious diseases early when they are easier to treat.

For health plans, MediCheck™ by ExamOne offers a streamlined approach to monitoring health conditions in members. This innovative program allows health plans to control the health risk assessment process and encourage healthy living to improve member outcomes. By removing the guesswork in health data, plans are better able to drive improvement in the health of their members.

One of the screens available through MediCheck is the InSure® FIT™ colorectal cancer screen. This in-home, water-based test kit makes it easy for individuals to complete the screening. InSure FIT is proven to detect stages I-III of colorectal cancers and requires no food or medicinal restrictions and no fecal handling. Learn more about the InSure FIT test.

Show your support for men’s health by wearing blue this month, and get more information about prevention from MensHealthMonth.org.

------------

1Men: Stay Healthy at Any Age: 2014 Update. March 2014. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/patients-consumers/patient-involvement/healthy-men/healthy-men.html

Read More

Do You Want to Improve Your Completion Rate? 05-29-2015

May 29, 2015 - The industry average turnaround time is two weeks. Schedule Now averages a turnaround time of one week by using multiple locations, real-time scheduling and more accurate examiner calendars.

Applicant convenience is the most important piece of scheduling and we offer multiple location options - home, work, a local ExamOne office or one of our Quest Diagnostics Patient Service Centers. Schedule Now allows for real-time scheduling with live examiner calendars. The available appointment times even include estimated travel time by calculating how long it would take an examiner to travel from their previous appointment to your applicant's location.

How It Works

  1. Multiple locations provide more convenience.
  2. Accurate calendar availability sets realistic expectations for a better applicant experience.
  3. Faster scheduling reduces buyer's remorse and improves your completion percentage.

To learn more about how your business can benefit from Schedule Now, contact your local ExamOne representative or email us today.

Read More

More Than 800,000 Applicants Have Viewed Their Results Online 04-29-2015

April 29, 2015 - With our online laboratory results we’re sharing more than just test values. The information we deliver includes detailed insight empowering applicants to take action.

  • Four years ago we committed to ensuring every applicant has convenient, online access to his or her laboratory results.
  • Today, more than 800,000 life insurance applicants have viewed their laboratory results via our dedicated applicant website, MyExamOne.com.
  • We have received thousands of positive comments from applicants such as, “The test results were easy to access…the diagram is fantastic and very informative. Thank you for this service and format…excellent!”

The public demand for this type of health data has been validated. A final rule issued in February 2014, by the U.S. Department of Health and Human Services (HHS)  amended the Clinical Laboratory Improvement Amendments of 1988 (CLIA) regulations to give patients (or their representatives) direct access to the patient’s laboratory test reports.

“Access to laboratory test results is essential for consumers who want to take responsibility for their health and can also be an important tool in helping improve mortality,” said Troy Hartman, ExamOne president. “We are proud of our clients and our laboratory for being ahead of government regulations by introducing this consumer tool several years in advance.”

Watch our video to learn more and be sure to encourage your applicants to utilize this tool.

Read More

Inclement Weather - Office Closings 3/13/2014 03-13-2014

3/13/2014 9:00 a.m. 

Due to road conditions, the following office will be delayed in opening:

Cleveland, OH

Read More

Inclement Weather - FedEx Update 02-18-2015

February 18, 2015 

Due to to inclement weather in Memphis, FedEx was unable to deliver specimens as scheduled yesterday morning to our Lenexa site.  We had anticipated their arrival yesterday afternoon, but they again were unable to make a delivery.  Specimens arrived on site this morning at 8am and we will process everything as expeditiously as possible.  While we received a large shipment, there are still specimens awaiting transport to Kansas City from Memphis.

Throughout this period of time, FedEx was able to deliver specimens to our St. Louis laboratory and they have been processed as expected.

We appreciate your patience and understanding as we work through these weather-related delays and apologize for any inconvenience this has caused. 

Read More

Inclement Weather - FedEx Update 02-18-2015

February 18, 2015 

Due to to inclement weather in Memphis, FedEx was unable to deliver specimens as scheduled yesterday morning to our Lenexa site.  We had anticipated their arrival yesterday afternoon, but they again were unable to make a delivery.  Specimens arrived on site this morning at 8am and we will process everything as expeditiously as possible.  While we received a large shipment, there are still specimens awaiting transport to Kansas City from Memphis.

Throughout this period of time, FedEx was able to deliver specimens to our St. Louis laboratory and they have been processed as expected.

We appreciate your patience and understanding as we work through these weather-related delays and apologize for any inconvenience this has caused. 

Read More

2014 ExamOne Holiday Hours 12-05-2014

ExamOne Specimen Processing & Imaging

Christmas Eve – Processing up to 5:30 p.m. Central Standard Time; Imaging – to 7:00 p.m. Central Standard Time

Christmas Day -  Closed

New Year's Eve - Processing up to 5:30 p.m. Central Standard Time; Imaging – Processing up to 7:00 p.m. Central Standard Time 

New Year's Day - Closed

APS

The APS department will be closed on Christmas Day and New Year’s Day.  

Teleunderwriting

Christmas Eve – 8:00 a.m. to 5:00 p.m. Central Standard Time

Christmas Day – Closed 

New Year’s Eve – 8:00 a.m. to 5:00 p.m. Central Standard Time

New Year’s Day – Closed 

CSG/Solutions Center

Christmas Eve - 8:00 a.m. to 5:00 p.m. Central Standard Time

Christmas Day - Closed

New Year's Eve - 8:00 a.m. to 5:00 p.m. Central Standard Time

New Year's Day  - Closed 

Read More

Recent Quest Diagnostics Health Trends™ Study Indicates Rise in Diabetes Diagnoses

May 11, 2015 - A recent Quest Diagnostics study indicated a significant rise in new diabetes cases in states that expanded Medicaid eligibility under the Affordable Care Act. The... Read full article

Quest Diagnostics Showcases Care360 EHR

MADISON, New Jersey, March 24, 2011 – Later this month, Quest Diagnostics will demonstrate how physicians can benefit from $39 billion in federal incentives by utilizing Care360™ EHR. The 12-week... Read full article

OVA1 Blood Test Detects Cancer More Accurately

OVA1 Blood Test Detects Ovarian Cancer More Accurately Than Medically Accepted CA 125 Method for Evaluating Women with Ovarian Mass

MADISON, N.J. and AUSTIN, Texas, May 12, 2011 /PRNewswire... Read full article

Quest Diagnostics Reports Strong Performance in Third Quarter 2009

- Total revenues of $1.9 billion, up 3.9%
- Diluted earnings of $1.02 per share, up 26%
- Cash flow from operations of $374 million, up 14%
- 2009 EPS outlook increased to a... Read full article

Contact Us

For more information about our products and services, or to find address, phone or email information, click here.

Take a Virtual Tour

Lab Image Gallery

 

 

  • "This is AMAZING to see the results broke down and explained so we can understand it. AWESOME!"*

  • "Very pleased and most impressed with the entire experience!"*

  • "I have been in the life insurance industry for a long time. This ExamOne service is IMPRESSIVE."*

  • "The ExamOne representative was great and the online system was easy to access and understand."*

  • "The entire process was flawless."*

*Based on 2015 survey.